Altimmune Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALT Nasdaq 2834 https://altimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Altimmune Inc

Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update - Aug 13th, 2019 2:15 pm
Germantown biopharma regains compliance with Nasdaq - Aug 7th, 2019 9:27 am
Altimmune to Announce Second Quarter 2019 Financial Results on August 14 - Aug 5th, 2019 5:00 am
Altimmune Announces Closing of Acquisition of Spitfire Pharma, Inc. - Jul 15th, 2019 5:00 am
Not just a vaccine company: How this Gaithersburg biotech CEO plans to grow the business - Jul 12th, 2019 12:55 pm
Altimmune to acquire California company for up to $93M - Jul 9th, 2019 2:45 pm
Germantown stem cell therapy company proposes $7M offering amid delisting threat - Jul 9th, 2019 11:39 am
Altimmune To Acquire Spitfire Pharma For $5M, Add NASH Drug To Portfolio - Jul 9th, 2019 6:48 am
Altimmune's stock soars after adding NASH candidate with purchase of Spitfire Pharma - Jul 9th, 2019 5:15 am
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio - Jul 9th, 2019 5:00 am
Altimmune Appoints Will Brown as Chief Financial Officer - Jun 12th, 2019 6:00 am
Altimmune Announces Successful Pre-IND Meeting with FDA - Jun 10th, 2019 6:00 am
Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs - Jun 5th, 2019 6:00 am
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update - May 14th, 2019 2:15 pm
Altimmune to Announce First Quarter 2019 Financial Results on May 15 - May 8th, 2019 6:00 am
Altimmune To Present NasoVAX Phase 2 Data at the World Vaccine Congress in Washington, D.C. - Apr 11th, 2019 7:27 am
Altimmune, Inc. to Host Earnings Call - Apr 2nd, 2019 4:30 am
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update - Apr 1st, 2019 2:20 pm
Altimmune to Announce Year End 2018 Financial Results on April 2 - Mar 21st, 2019 2:15 pm
Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data - Mar 19th, 2019 10:21 am